Yabao Pharmaceutical Group Co., Ltd

¥6.85As of Sun 8 Nov 2026, 12:00 UTC
SSE:600351Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (1.62%)
Div yield 4.38%
ROE 13.13%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.14
PE TTM 13.12
TSR TTM 10.68%
Mkt cap ¥4.740B
ROIC 14.27%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥8.89
29.80%
(2.73%)
Hold 5|8|7|3|5
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.09
0.10
0.11
0.11
22.74%
26.25%
33.32%
32.74%
Revenue¥M
273.5
268.2
261.2
254.4
(0.67%)
(0.42%)
(1.86%)
(3.23%)
Peers (US$710.6M)
Cap (US$)
PE
712.5M
—
Capital
TTM
5Y
10Y
Leveragex
0.577
(0.135)
(0.096)
EBIT/Intx
3.403
0.332
0.329
Own earn%
13.52
56.05
40.68
Sh yield%
40.43
20.01
18.39
Owners
Insiders/Inst%
4.36
20.12
Short interest%
3.89
SBC / revenue%
2.75
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
27–32
$1 testx
0.3
Incr. ROIC%
1